探索se-methylselenocysteine对GC-1/GC-2细胞的有益影响:从细胞吸收到男性繁殖中的代谢途径调节
Yiqing Lu1,2, Xiaofei Duan1,2, Huatao Che2
1Institute of Crop Science, Zhejiang University, Hangzhou 310058, China.
Antioxidants (Basel, Switzerland)
|February 27, 2026
概括
甲基氨基 (MeSeCys) 通过增加和谷氨水平,增强男性生殖细胞的活力. 这种有机补充剂显示了改善男性生育能力和生殖健康的潜力.
科学领域:
- 生殖生物学 生殖生物学
- 营养生物化学 营养生物化学
- 细胞的新陈代谢
背景情况:
- 男性不孕症,以精子生成失败为特征,是全球重要的健康问题.
- (Se) 对于正常的精子生成至关重要,并且有机形式如Se-methylselenocysteine (MeSeCys) 提供抗氧化和抗炎功效.
- MeSeCys对男性生殖细胞的特定影响需要进一步研究.
研究的目的:
- 研究Se-methylselenocysteine (MeSeCys) 对男性生殖细胞系 (GC-1和GC-2) 的影响.
- 探索细胞吸收机制和对细胞内水平的影响.
- 阐明这些细胞中MeSeCys调节的分子通路.
主要方法:
- 用75μmol/L的MeSeCys对GC-1和GC-2细胞系进行24小时的治疗.
- 评估细胞活力和细胞内含量.
- RNA测序 (RNA-seq) 和生物信息学分析以确定受影响的途径.
- 通过SLC7A11或LRP8通道对MeSeCys吸收的调查.
主要成果:
- MeSeCys显著提高了GC-1和GC-2细胞的活力,对GC-1的影响更大.
- 证实了MeSeCys的吸收,导致细胞内水平升高,特别是在GC-1细胞中.
- RNA-seq揭示了MeSeCys调节化合物和谷氨代谢,增加细胞内谷氨 (GSH) 水平.
- 在GC-1细胞中,MeSeCys专门调节mTOR通路,影响氧化还原平衡.
结论:
- MeSeCys通过增强活力和氧化还原平衡,对男性生殖细胞系产生有益影响.
- 该化合物影响和谷的新陈代谢,可能通过GC-1细胞中的mTOR途径.
- MeSeCys具有作为支持男性生殖健康的营养补充剂的潜力.
更多相关视频
09:41Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
Published on: December 28, 2021
2.3K
13:22A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System
Published on: September 10, 2013
12.6K
相关概念视频
Sulfur Assimilation
434
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
434
Mutagenicity and Carcinogenicity
2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
